GT Biopharma, Inc.
New Filing
CIK: 0000109657·Biotechnology·FLORIDA·Filed: Sep 14, 2017
Total Offering
$4,540,000
Amount Sold
$4,540,000
Investors
9
First Sale
Aug 31, 2016
Offering Details
- Type
- Equity, Debt
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Kathleen Clarence-Smith | Related Person |
| Anthony Cataldo | Related Person |
| Steven Weldon | Related Person |
Company
SEC Filing
0000939798-17-000077
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free